Showing 44,481 - 44,500 results of 112,387 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (fold decrease)) ))', query time: 1.02s Refine Results
  1. 44481
  2. 44482

    DataSheet1_A focus on CKD reporting and inappropriate prescribing among older patients discharged from geriatric and nephrology units throughout Italy: A nationwide multicenter ret... by Filippo Aucella (821349)

    Published 2022
    “…Overall, the study population consisted of 2,057 patients, aged 83 (77–89) years, more commonly women, with a median of seven (5–10) drugs prescribed at discharge. …”
  3. 44483
  4. 44484
  5. 44485

    The Timing of Cancer Onset Is Correlated with the Most Common First Two Mutations of a Tumor by Sabrina L Spencer (20366)

    Published 2013
    “…<p>The most common first two mutations of a tumor define the dominant tumor type. <i>GI</i> is the most common first mutation in the 0–5 K timeblock, as seen by summing the populations with <i>GI</i> as the first mutation. …”
  6. 44486

    ATI markers are reduced in <i>Sema3A<sup>-/-</sup></i> mice. by Patrice M. Becker (339730)

    Published 2013
    “…</b> Western blotting demonstrates decreased expression of both T1-alpha (left) and Aqp5 (right) protein in lung homogenate from <i>Sema3A<sup>-/-</sup></i> animals as compared with <i>Sema3A<sup>+/+</sup></i> littermate controls. …”
  7. 44487
  8. 44488
  9. 44489

    CAU-52: An Iron Metal–Organic Framework Containing Furandicarboxylate Linker Molecules by Essam Alkhnaifes (21011246)

    Published 2025
    “…The V-shaped linker molecule 2,5-furandicarboxylic acid (H<sub>2</sub>FDC), which can be derived from lignocellulosic biomass, was used in a systematic screening with various iron salts and led to the discovery of a new iron-based metal–organic framework (Fe-MOF) with the composition [Fe<sub>3</sub>(μ<sub>3</sub>-O)(FDC)<sub>3</sub>(OH)(H<sub>2</sub>O)<sub>2</sub>]·5H<sub>2</sub>O·H<sub>2</sub>FDC, designated as CAU-52 (CAU = Christian-Albrechts-Universität zu Kiel). …”
  10. 44490

    CAU-52: An Iron Metal–Organic Framework Containing Furandicarboxylate Linker Molecules by Essam Alkhnaifes (21011246)

    Published 2025
    “…The V-shaped linker molecule 2,5-furandicarboxylic acid (H<sub>2</sub>FDC), which can be derived from lignocellulosic biomass, was used in a systematic screening with various iron salts and led to the discovery of a new iron-based metal–organic framework (Fe-MOF) with the composition [Fe<sub>3</sub>(μ<sub>3</sub>-O)(FDC)<sub>3</sub>(OH)(H<sub>2</sub>O)<sub>2</sub>]·5H<sub>2</sub>O·H<sub>2</sub>FDC, designated as CAU-52 (CAU = Christian-Albrechts-Universität zu Kiel). …”
  11. 44491

    Data_Sheet_1_Sleeping <6.55 h per day was associated with a higher risk of low back pain in adults aged over 50 years: a Korean nationwide cross-sectional study.PDF by Dexin Hu (19710271)

    Published 2024
    “…Each additional hour of sleep was associated with a 13.6% decrease in the risk of LBP. No significant association was observed between sleep duration ≥6.55 h and the risk of LBP. …”
  12. 44492
  13. 44493
  14. 44494
  15. 44495

    A Novel Network Profiling Analysis Reveals System Changes in Epithelial-Mesenchymal Transition by Teppei Shimamura (133856)

    Published 2011
    “…As a result, we found that knockdown of KLF5 by siRNA significantly decreased E-cadherin expression and induced morphological changes characteristic of EMT. …”
  16. 44496
  17. 44497

    IntegraBrain: A multi-modal neural interface for the detection and suppression of focal epilepsy by Spencer Moore (8440863)

    Published 2025
    “…</p><p dir="ltr">The Interface consists of discrete electronic components embedded in a mechanically soft matrix with the dimensions 9.5 x 9.5 x 2.5mm. …”
  18. 44498
  19. 44499
  20. 44500

    Blockade of Alk receptor activation abolishes neuronal differentiation due to Activin A treatment. by Griselda Rodríguez-Martínez (140821)

    Published 2012
    “…Addition of growth factors and inhibitors was made every other day. SB431542 (Alk4, Alk5 and Alk7 inhibitor, 5 µM), Follistatin (Activin A ligand-trap, 20 ng/ml) or Dorsomorphin (BMP antagonists, 5 µM) were added to NPC cultures 1 hour previous to Activin A. …”